Found 1 clinical trials
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)
The objectives of this study are to evaluate the safety and efficacy of Zimura intravitreal administration in patients with geographic atrophy secondary to age-related macular degeneration (AMD)
atrophy
age-related macular degeneration
complement c5
macular degeneration
geographic atrophy
- 0 views
- 16 Feb, 2024
- 23 locations